naphtalina/iStock via Getty Images
- Global WholeHealth Partners (OTCPK:GWHP) has signed a binding MOU with Pan Probe Biotech and AvantGen to develop the newest COVID-19 antigen test.
- The company develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad.
- Global WholeHealth said that it is confident in the new partnerships to produce the best COVID antigen test on the market.